Petros Pharmaceuticals, Inc. Stock Split Ratio
Petros Pharmaceuticals, Inc. (PTPI) reported Stock Split Ratio of 4.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-13
- 2025-09-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month 4.00%.
- 2025-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month 4.00%.
- 2025-04-29: Stockholders' Equity Note, Stock Split, Conversion Ratio 4.00%.
- 2022-11-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month |
|---|---|---|---|
| 2025-09-30 | 4.00% 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | 4.00% 10-Q · filed 2025-08-14 | ||
| 2025-04-29 | 4.00% 10-Q · filed 2026-08-13 | ||
| 2022-11-30 | 10.00% 10-K · filed 2024-04-01 | ||
| 2020-11-30 | 10.00% 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |